Dyne Therapeutics (DYN) Common Equity (2019 - 2026)
Dyne Therapeutics' Common Equity was $702.15 million in Q2 2026, up 22.9% from $571.45 million a year earlier but down 18.8% from the prior quarter.
Dyne Therapeutics (DYN) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Dyne Therapeutics came in at $972.13 million, up 54.3% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
- In earlier years, Common Equity was $629.84 million in FY2024 (+589.9%), $91.29 million in FY2023 (-63.8%), $252.36 million in FY2022 (-31.5%) and $368.2 million in FY2021 (+7.5%).
- Quarterly Common Equity has moved between $91.29 million (Q4 2023) and $972.13 million (Q4 2025) over five years.
- Compared with a year earlier, Common Equity has increased for three straight quarters, with growth averaging 134.0% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q4 2024 (growth of 589.9%); the worst was Q4 2023 (a decline of 63.8%).
- Per Business Quant data, DYN's Common Equity in the three quarters before Q2 2026 was $865.06 million (Q1 2026), $972.13 million (Q4 2025) and $691.78 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Dyne Therapeutics | 2.71 Bn | 2.71 Bn | - | 702.15 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 702.15 Mn |
| Mar 31, 2026 | 865.06 Mn |
| Dec 31, 2025 | 972.13 Mn |
| Sep 30, 2025 | 691.78 Mn |
| Jun 30, 2025 | 571.45 Mn |
| Mar 31, 2025 | 668.97 Mn |
| Dec 31, 2024 | 629.84 Mn |
| Sep 30, 2024 | 705.54 Mn |
| Jun 30, 2024 | 775.19 Mn |
| Mar 31, 2024 | 478.06 Mn |
| Dec 31, 2023 | 91.29 Mn |
| Sep 30, 2023 | 152.04 Mn |
| Jun 30, 2023 | 206.88 Mn |
| Mar 31, 2023 | 241.94 Mn |
| Dec 31, 2022 | 252.36 Mn |
| Sep 30, 2022 | 249.74 Mn |
| Jun 30, 2022 | 287.06 Mn |
| Mar 31, 2022 | 336.46 Mn |
| Dec 31, 2021 | 368.20 Mn |
| Sep 30, 2021 | 414.12 Mn |
Dyne Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DYN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DYN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DYN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();